# LEO 124249 Ointment in the Treatment of Alopecia Areata

> **NCT02561585** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 40 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** LEO 124249
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT02561585
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561585, "LEO 124249 Ointment in the Treatment of Alopecia Areata". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02561585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*